|
1
|
Templeton AJ, McNamara MG, Šeruga B,
Vera-Badillo FE, Aneja P, Ocaña A, Leibowitz-Amit R, Sonpavde G,
Knox JJ, Tran B, et al: Prognostic role of neutrophil-to-lymphocyte
ratio in solid tumors: A systematic review and meta-analysis. J
Natl Cancer Inst. 106:dju1242014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xue TC, Zhang L, Xie XY, Ge NL, Li LX,
Zhang BH, Ye SL and Ren ZG: Prognostic significance of the
neutrophil-to-lymphocyte ratio in primary liver cancer: A
meta-analysis. PLoS One. 9:e960722014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Walsh SR, Cook EJ, Goulder F, Justin TA
and Keeling NJ: Neutrophil-lymphocyte ratio as a prognostic factor
in colorectal cancer. J Surg Oncol. 91:181–184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kang MH, Go SI, Song HN, Lee A, Kim SH,
Kang JH, Jeong BK, Kang KM, Ling H and Lee GW: The prognostic
impact of the neutrophil-to-lymphocyte ratio in patients with
small-cell lung cancer. Br J Cancer. 111:452–460. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lieto E, Galizia G, Auricchio A, Cardella
F, Mabilia A, Basile N, Del Sorbo G, Castellano P, Romano C,
Orditura M and Napolitano V: Preoperative neutrophil to lymphocyte
ratio and lymphocyte to monocyte ratio are prognostic factors in
gastric cancers undergoing surgery. J Gastrointest Surg.
21:1764–1774. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cho H, Hur HW, Kim SW, Kim SH, Kim JH, Kim
YT and Lee K: Pre-treatment neutrophil to lymphocyte ratio is
elevated in epithelial ovarian cancer and predicts survival after
treatment. Cancer Immunol Immunother. 58:15–23. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hu H, Yao X, Xie X, Wu X, Zheng C, Xia W
and Ma S: Prognostic value of preoperative NLR, dNLR, PLR and CRP
in surgical renal cell carcinoma patients. World J Urol.
35:261–270. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ohno Y, Nakashima J, Ohori M, Hatano T and
Tachibana M: Pretreatment neutrophil-to-lymphocyte ratio as an
independent predictor of recurrence in patients with nonmetastatic
renal cell carcinoma. J Urol. 184:873–878. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cetin B, Berk V, Kaplan MA, Afsar B, Tufan
G, Ozkan M, Isikdogan A, Benekli M, Coskun U and Buyukberber S: Is
the pretreatment neutrophil to lymphocyte ratio an important
prognostic parameter in patients with metastatic renal cell
carcinoma? Clin Genitourin Cancer. 11:141–148. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fox P, Hudson M, Brown C, Lord S, Gebski
V, De Souza P and Lee CK: Markers of systemic inflammation predict
survival in patients with advanced renal cell cancer. Br J Cancer.
109:147–153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Frank I, Blute ML, Cheville JC, Lohse CM,
Weaver AL and Zincke H: An outcome prediction model for patients
with clear cell renal cell carcinoma treated with radical
nephrectomy based on tumor stage, size, grade and necrosis: The
SSIGN score. J Urol. 168:2395–2400. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Leibovich BC, Blute ML, Cheville JC, Lohse
CM, Frank I, Kwon ED, Weaver AL, Parker AS and Zincke H: Prediction
of progression after radical nephrectomy for patients with clear
cell renal cell carcinoma: A stratification tool for prospective
clinical trials. Cancer. 97:1663–1671. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Patard JJ, Kim HL, Lam JS, Dorey FJ,
Pantuck AJ, Zisman A, Ficarra V, Han KR, Cindolo L, De La Taille A,
et al: Use of the University of California Los Angeles integrated
staging system to predict survival in renal cell carcinoma: An
international multicenter study. J Clin Oncol. 22:3316–3322. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Karakiewicz PI, Suardi N, Capitanio U,
Jeldres C, Ficarra V, Cindolo L, de la Taille A, Tostain J, Mulders
PF, Bensalah K, et al: A preoperative prognostic model for patients
treated with nephrectomy for renal cell carcinoma. Eur Urol.
55:287–295. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lou M, Luo P, Tang R, Peng Y, Yu S, Huang
W and He L: Relationship between neutrophil-lymphocyte ratio and
insulin resistance in newly diagnosed type 2 diabetes mellitus
patients. BMC Endocr Disord. 15:92015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shiny A, Bibin YS, Shanthirani CS, Regin
BS, Anjana RM, Balasubramanyam M, Jebarani S and Mohan V:
Association of neutrophil-lymphocyte ratio with glucose
intolerance: An indicator of systemic inflammation in patients with
type 2 diabetes. Diabetes Technol Ther. 16:524–530. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Larsson SC and Wolk A: Diabetes mellitus
and incidence of kidney cancer: A meta-analysis of cohort studies.
Diabetologia. 54:1013–1018. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bao C, Yang X, Xu W, Luo H, Xu Z, Su C and
Qi X: Diabetes mellitus and incidence and mortality of kidney
cancer: A meta-analysis. J Diabetes Complications. 27:357–364.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Balkwill FR and Mantovani A:
Cancer-related inflammation: Common themes and therapeutic
opportunities. Semin Cancer Biol. 22:33–40. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chan AT, Ogino S and Fuchs CS: Aspirin and
the risk of colorectal cancer in relation to the expression of
COX-2. N Eng J Med. 356:2131–2142. 2007. View Article : Google Scholar
|
|
21
|
Sparmann A and Bar-Sagi D: Ras-induced
interleukin-8 expression plays a critical role in tumor growth and
angiogenesis. Cancer Cell. 6:447–458. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stoppacciaro A, Melani C, Parenza M,
Mastracchio A, Bassi C, Baroni C, Parmiani G and Colombo MP:
Regression of an established tumor genetically modified to release
granulocyte colony-stimulating factor requires granulocyte-T cell
cooperation and T cell-produced interferon gamma. J Exp Med.
178:151–161. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Avci A, Elnur A, Göksel A, Serdar F,
Servet I, Atilla K, Mustafa TM, Cuneyt T, Yeliz G, Mustafa B and
Metin EA: The relationship between neutrophil/lymphocyte ratio and
calcific aortic stenosis. Echocardiography. 31:1031–1035. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Balta S, Demirkol S, Kucuk U, Celik T,
Ozturk C and Iyisoy A: The relationship between
neutrophil-lymphocyte ratio and coronary collateral circulation.
Perfusion. 29:367–368. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yao C, Liu X and Tang Z: Prognostic role
of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for
hospital mortality in patients with AECOPD. Int J Chron Obstruct
Pulmon Dis. 12:2285–2290. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Demir M: The relationship between
neutrophil lymphocyte ratio and non-dipper hypertension. Clin Exp
Hypertens. 35:570–573. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ha YS, Kim WT, Yun SJ, Lee SC, Kim WJ,
Park YH, Kang SH, Hong SH, Byun SS and Kim YJ: Multi-institutional
analysis of localized renal cell carcinoma that demonstrates the
impact of diabetic status on prognosis after nephrectomy. Ann Surg
Oncol. 20:3662–3668. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen L, Li H, Gu L, Ma X, Li X, Gao Y,
Zhang Y, Shen D, Fan Y, Wang B, et al: The impact of diabetes
mellitus on renal cell carcinoma prognosis: A meta-analysis of
cohort studies. Medicine (Baltimore). 94:e10552015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Boissier R, Campagna J, Branger N,
Karsenty G and Lechevallier E: The prognostic value of the
neutrophil-lymphocyte ratio in renal oncology: A review. Urol
Oncol. 35:135–141. 2017. View Article : Google Scholar : PubMed/NCBI
|
